WASHINGTON (AP) - A less costly implantable defibrillator for heart patients was approved Thursday by the Food and Drug Administration.
These devices are placed in the chest of a patient at risk of dying from sudden cardiac arrest. The defibrillator can sense heart function and automatically deliver an electrical shock to restore normal heart rhythm.
The FDA said the newly approved product, made by Biotronik Inc. of Lake Oswego, Ore., will cost $10,000, about half the price of others on the market. It has fewer features than the more costly models.
The device can deliver a shock to deal with life-threatening conditions, but it does not offer lower-energy heart pacing therapy that other models provide.
Copyright © 2003 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.